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Background: Despite a vast literature, atherosclerosis and the associated ischemia/
reperfusion injuries remain today in many ways a mystery. Why do atheromatous
plaques make and store a supply of cholesterol and sulfate within the major arteries
supplying the heart? Why are treatment programs aimed to suppress certain
myocardial infarction risk factors, such as elevated serum homocysteine and
inflammation, generally counterproductive?
Methods: Our methods are based on an extensive search of the literature in
atherosclerotic cardiovascular disease as well as in the area of the unique properties
of water, the role of biosulfates in the vascular wall, and the role of electromagnetic
fields in vascular flow. Our investigation reveals a novel pathology linked to
atherosclerosis that better explains the observed facts than the currently held
popular view.
Results: We propose a novel theory that atherosclerosis can best be explained as
being due to cholesterol sulfate deficiency. Furthermore, atheromatous plaques
replenish the supply of cholesterol and sulfate to the microvasculature, by exploiting
the inflammatory agent superoxide to derive sulfate from homocysteine and other
sulfur sources. We argue that the sulfate anions attached to the glycosaminoglycans
in the glycocalyx are essential in maintaining the structured water that is crucial for
vascular endothelial health and erythrocyte mobility through capillaries. Sulfate
depletion leads to cholesterol accumulation in atheromas, because its transport
through water-based media depends on sulfurylation. We show that streaming
potential induces nitric oxide (NO) release, and NO derivatives break down the
extracellular matrix, redistributing sulfate to the microvasculature. We argue that low
(less negative) zeta potential due to insufficient sulfate anions leads to hypertension
and thrombosis, because these responses can increase streaming potential and induce
nitric-oxide mediated vascular relaxation, promoting oxygen delivery. Our hypothesis is
a parsimonious explanation of multiple features of atherosclerotic cardiovascular
disease.
Conclusions: If our interpretation is correct, then it would have a significant impact
on how atherosclerosis is treated. We recommend a high intake of sulfur-containing
foods as well as an avoidance of exposure to toxicants that may impair sulfate
synthesis.© 2015 Seneff et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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After many years of research, atherosclerosis and the associated risk of myocardial in-
farction (MI), the number one cause of death worldwide, remains a well-studied but
poorly understood condition. Several risk factors have been identified, such as elevated
serum low density lipoprotein (LDL), low cholesterol content in high density lipopro-
tein (HDL), elevated serum homocysteine, diabetes, left ventricular hypertrophy, etc.
[1], but it remains controversial whether these risk factors are merely associative or
actual causes. Particularly troublesome is the paradoxical reverse epidemiology profile
of people suffering from end stage kidney disease [2] and other chronic inflammatory
conditions such as systemic lupus erythematosus [3]. Here, the normal risk factors –
obesity, high blood pressure, high cholesterol, and high homocysteine – all become
protective factors in heart disease risk. And these patients have extremely high risk of
heart disease (this is in fact their most common cause of death) [4], despite the inversion
of risk factors.
Increasingly, atherosclerosis is framed as an inflammatory condition [5–7], and
clearly inflammation plays a critical role in vascular dysfunction. Ischaemic tissue will
face necrosis if it is not reperfused, yet reperfusion can also lead to severe tissue dam-
age due to oxidative attack [8]. Inflammation is the one factor that is strongly linked to
cardiac disease in association with kidney failure [9, 10]. Others have proposed that
atherosclerosis is an infectious disease, as infective agents, especially Chlamydia pneu-
moniae and Herpes virus, have been found consistently in association with atheroscler-
otic plaque regions [11, 12].
Results and discussion
In this paper we present an alternative view of atherosclerosis as a set of responses aimed
at correcting disturbances in biological water structure caused by depletion of crucial
biosulfates – especially sulfurylated1 cholesterol and glycosaminoglycans (GAGs) – in the
cardiovascular system. Evidence for a role of sulfur deficiency in atherosclerosis will be
surveyed in (Evidence for a role of sulfur deficiency in atherosclerosis below). In Sections
(The Exogenous Interfacial Water Stress (EIWS) theory of inflammation, Electrokinetic
vascular streaming potential and Biosulfates as enablers of healthy blood flow), we con-
sider the biophysics of structured water and vascular streaming potential and the import-
ance of sulfates in maintaining them and in enabling healthy blood flow. In Section
(Extracellular matrix sGAG turnover as a mechanism for sulfate redistribution), we
discuss how sulfurylated GAG turnover in the vascular system may be used to redistribute
sulfate to replenish cholesterol sulfate levels in the capillaries. We will then turn our
attention in Section (Glutathione and GGT) to emergency routes – with damaging side
effects – by which the body may replenish vascular sulfate supplies by conversion of less-
oxidized sulfur compounds such as glutathione, H2S, and homocysteine to sulfate.
Evidence for a role of sulfur deficiency in atherosclerosis
While many research papers have described in detail the processes that take place in
the coronary artery wall in association with the accumulation of fat and cholesterol,
few have attempted to explain why these processes are happening. It is particularly sur-
prising that the arteries supplying the heart, arguably the most important organ in the
body, should be especially vulnerable to fatty deposits.
Seneff et al. Theoretical Biology and Medical Modelling  (2015) 12:9 Page 3 of 24In this section we will review the evidence for a role of sulfur deficiency in athero-
sclerosis. Table 1 provides a chronological list of key research and review papers point-
ing strongly to involvement of a variety of oxidized and reduced sulfur compounds in
this condition. These articles will be discussed in more detail at various points through-
out this paper.
Interesting early studies on the New World primate, Cebus fatuella, revealed that a
condition strongly resembling atherosclerosis could be produced in the artery wall by
feeding these monkeys a high fat, high cholesterol, high choline diet [13]. However, this
effect could be eliminated or drastically reduced if the monkeys were simultaneously
supplemented with sulfur-containing amino acids. Children with disorders of cysteine
metabolism leading to excess serum homocysteine develop arterial damage at an early
age that is reminiscent of atherosclerotic cardiovascular disease [14]. The consumption
of garlic is inversely correlated with the progression of atherosclerosis, and, in [15] it
was argued that the protective benefit is due to the ability of human erythrocytes to
convert garlic-derived polysulfides into hydrogen sulfide gas. These observations and
others strongly support the model that impaired sulfur supplies to the vasculature plays
a critical role in atherosclerosis.
In [16], the argument was developed that atherosclerosis results from a deficiency in
a critical nutrient, cholesterol sulfate (Ch-S), and that the atheroma is a locale whereTable 1 Timeline of significant research papers linking atherosclerosis with impaired sulfate supply
to the vasculature
Publication Key finding
Mann, 1960 [13] Sulfur supplementation protects monkeys from atherosclerosis, due to
dietary cholesterol and choline enrichment.
Hauss et al., 1962 [110] Chondroitin sulfate incorporation into connective tissue is greatly enriched
in the atherosclerotic aorta.
McCully, 1969 [14] Homocysteine plays an important role in arteriosclerosis.
Bleau et al., 1974 [84] Deficient Ch-S in RBCs leads to increased hemolysis; Ch-S stabilization
of RBC membrane by SEM.
Bergner et al., 1981 [32] Cholesterol sulfatase deficiency leads to massive accumulation of Ch-S
in RBCs and plasma.
Avila et al., 1996 [37] Chagas infection induces Ch-S autoantibodies.
Paka et al., 1999 [98] ApoE promotes both cholesterol egress from macrophages in the
plaque and sulfation of the glycocalyx.
Strott, 2003 [30] The only review article available on Ch-S’s role in physiology.
Freitas et al., 2005 [38] Chagas disease induces heart failure many years later; with minimal
evidence of cardiovascular disease.
Ren et al., 2007 [35] Ch-S regulates lipid metabolism in the liver.
Ma et al., 2008 [34] Ch-S decreases lipid biosynthesis in macrophages.
Qiao et al., 2010 [141] H2S is involved in pathogenesis of atherosclerosis.
Davidson and Seneff, 2012 [49] Sulfate deficiency leads to decreased deformability and increased
aggregation of RBCs, increased (less negative) zeta potential, and
increased capillary surface tension.
Manna and Jain, 2011 [118] H2S enhances glucose uptake by cells
Seneff et al., 2012 [16] eNOS produces sulfate catalyzed by sunlight.
Xu et al., 2012 [33] Ch-S suppresses inflammatory response in macrophages.
Xu et al., 2014 [142] H2S is a promising therapy for atherosclerosis.
Toshikuni et al., 2015 [130] Elevated serum GGT predicts carotid plaque build-up.
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cysteine and oxidized LDL. It was argued that an underlying deficiency in Ch-S, due
principally to insufficient dietary sulfur and inadequate sun exposure to the skin, leads,
over time, to severe depletion of cholesterol and sulfate in the tissues. This deficiency
becomes life-threatening with age, and atherosclerotic plaque is a well-choreographed
program for renewal of Ch-S. Unfortunately, there is necessarily collateral damage from
superoxide exposure, as superoxide is required to oxidize the LDL and to catalyze the
reaction that produces sulfate from homocysteine thiolactone [17].
Worldwide geographical data show an inverse relationship between cardiovascular
disease and annual sunlight availability [18]. In a study conducted in the British Isles,
49 % of the variance in mortality from coronary heart disease was accounted for by
mean annual sunshine hours as measured by the Meteorological Office [19]. However,
placebo-controlled trials failed to show any benefit from vitamin D3 supplementation
[20]. We propose that the benefit comes from Ch-S synthesis instead. In [16], it was
proposed that the protein endothelial nitric oxide synthase (eNOS), along with sunlight,
catalyzes sulfate production in erythrocytes, endothelial cells, platelets and keratino-
cytes in the skin. Thus, eNOS is a dual-purpose enzyme, producing sulfate when it is
membrane–bound and producing nitric oxide when it is free in the cytoplasm. We
hypothesize that the overuse of sunscreen has played a dual damaging role not only be-
cause sunlight catalysis is suppressed but also because the aluminum found in high-SPF
sunscreens as an emulsifier actively disrupts eNOS’ function [21]. eNOS is an orphan
cytochrome P450 (CYP) enzyme [22], and aluminum is a known disruptor of CYP en-
zyme function through its displacement of the iron in the heme group [23]. Many other
environmental toxicants also disrupt CYP enzymes, including mercury [24, 25], arsenic
[26], cadmium [24], glyphosate [27, 28], and lead [25, 29].
There exist a large number of different sulfatases and sulfotransferases that effect
sulfuryl group transfer from a source molecule to a target molecule, with an ATP-
activated form of sulfate, called 3′-phosphoadenosine-5′-phosphosulfate (PAPS) serving
as an intermediary [30, 31]. Sulfotransferase deficiency is associated with remarkable
accumulations of Ch-S in red blood cells (7500 μgrams/100 ml vs < 300 in controls)
and in plasma (3300 vs. < 350) [32]. This implies that Ch-S produced in erythrocytes
and the endothelial wall is essential for distributing both cholesterol and sulfate to the
tissues.
The nuclear receptor peroxisome proliferator-activated receptors (PPARs) regulate
both lipid metabolism and the inflammatory response in macrophages in the atheroma.
A recent experiment showed that 25-hydroxycholesterol sulfate (25HCS) activated
PPARγ in macrophages, resulting in the suppression of NF-κB and the subsequent
inflammatory response [33]. 25HCS also decreases lipid biosynthesis in both macro-
phages [34] and the liver [33, 35]. The unsulfurylated form of the molecule had the
opposite effect. This supports the idea that inflammation is needed for sulfate synthesis
and that sulfate is needed for cholesterol export.
MI is an acute response to interruption of the blood supply to a part of the heart,
usually assumed to be caused by the rupture of vulnerable plaque occluding the artery
wall. However, in about 10 % of patients, there is no apparent plaque accumulation
associated with the acute event. Despite this apparently healthy arterial profile, such
individuals experience a similar incidence of death and recurrent MI in long-term
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case in this regard is the myocardial dysfunction associated with Chagas disease [37].
Trypanosoma cruzi (Chagas disease) is a parasitic infection that occurs predominantly
in South America, where an individual infected early in life experiences a substantially
increased risk to premature heart failure many decades later [38, 39]. While there is a
substantial impairment in heart function associated with Chagas disease, including car-
diomyopathy and left ventricular hypertrophy, people with this condition are remark-
ably free from atherosclerotic plaque build-up.
We propose that this unusual profile is due to the fact that T. cruzi produces a ster-
oid that remarkably resembles Ch-S. A study revealed that 86 % of the Chagas patients
tested had developed autoantibodies against Ch-S – a very specific effect in that closely
related steroid sulfates were not affected [37]. Thus, the atheroma is unable to function
in the normal role of producing Ch-S, due to the autoimmune reaction this would pro-
voke. As a consequence, the heart develops severe cumulative impairment over time,
due to deficiencies in cholesterol and sulfate supplies, ironically caused by the absence
of atherosclerosis.
The most precarious phase of an MI is reperfusion rather than ischemia, as reperfu-
sion injury can be extensive and life-threatening [40]. Reperfusion injury is associated
with systemic exposure to inflammation from superoxide and its reaction products,
which is believed to be the principle source of injury [40, 41]. Ischemic reperfusion is
characterized by a complex sequence of events leading in extreme cases to systemic in-
flammation and edema, microvascular dysfunction (the “no flow” phenomenon) and
multiple organ failure, the leading cause of death in the critically ill [41].
Thus, a local blockage, for example due to thrombosis or traumatic injury, whether
in the heart or elsewhere, can lead, through complex signaling cascades, to a systemic
response – a catastrophic failure in the blood transport system – which appears to be
the ultimate cause of death in these cases. Most interesting, however, is the observation
that suppression of the systemic response through drug intervention results in a sub-
stantial worsening of tissue damage via extensive apoptosis at the local site [42]. Thus,
the systemic response can lead to a positive outcome: it produces some product that
somehow protects cells at the site of injury from apoptosis.
In addition to Ch-S, the sulfurylated glycosaminoglycans (GAGs) that comprise the
so-called glycocalyx structures lining the endothelial lumen also appear to contribute
importantly to cardiovascular health [43]. These sGAGs contain linear chains of modi-
fied sugar molecules such as heparan sulfate and chondroitin sulfate, which can be ei-
ther attached to membrane-bound proteins or free floating. Pericytes are a specialized
cell type that has gained attention in recent years due to the realization that they are
essential for the health of capillaries, arterioles and venules, and that they are particu-
larly prevalent in the brain [44]. Pericytes are situated in the microenvironmental niche
of the arteriole or venule wall, and they differentiate into different cell types in response
to environmental stress signals, to assist with tissue regeneration and repair [45]. Peri-
cytes wrap around endothelial cells and are in close communication with them through
junctional complexes. The migration of pericytes depends on paracrine signaling from
growth factors like vascular endothelial growth factor (VEGF) and platelet derived
growth factor (PDGF). In [46], it was shown that the PDGF-mediated recruitment of
pericytes to the capillary wall critically depends on sufficient N-sulfurylation of heparan
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(NDSTs) are essential for the sulfurylation process [47], and mice with a deficiency in
NDST-1, the major N-sulfurylating enzyme [48], often die in utero, or live for just a
few days following birth. Microscopic examination of the brain vasculature revealed se-
vere depletion in pericytes.
The contribution of sGAGs to cardiovascular health rests on their ability to maintain
specially-structured water zones in the blood vessels. This topic will be explored in
more detail in the following three sections.The Exogenous Interfacial Water Stress (EIWS) theory of inflammation
As noted above, atherosclerosis is increasingly regarded as an inflammatory condition
[5–7]. In earlier reviews, Davidson and Seneff have proposed exogenous interfacial
water stress (EIWS) – the disruption of normal interfacial tension between water and
biomacromolecules in vivo by exogenous agents such as the aluminum aquo cation –
as the earliest step in the pathogenesis of inflammation and disease [49, 50].
In this section, we will focus on biophysical properties of interfacial water that are
relevant for blood flow in the vascular system. In the next section, we will discuss
streaming potential, and its important role in inducing nitric oxide synthesis. We will
follow this with a section that considers in more detail the roles played by biological
sulfate species, including sGAGs and Ch-S, in maintaining healthy interfacial water
structure and enabling blood flow.
A full description of the complex biophysics of dynamically-structured water and its
electrokinetic properties is beyond the scope of this paper. However, several recent review
articles can be cited [51–54]. It has become abundantly clear that water is an active and
even key participant in chemical reactions, and is, furthermore, the natural environment
for biochemical processes [54]. Moreover, the interaction of water with the solutes and
surfaces encountered in biological systems at relatively close range results in water prop-
erties that vary substantially from those measured for the pure bulk liquid.
In 2012, Davidson and Seneff [49] presented for the first time a number of novel
biophysically-based hypotheses as to the role of interfacial water, sunlight, and the
biosulfates in facilitating and enabling microvascular blood flow and gas exchange. The
concept of surfactant-induced interfacial water stress was presented, and the conclusion
was reached that the initial events in the inflammatory cascade are purely biophysical.
The role of the bio-sulfates in maintaining cell membrane function and the role of endo-
thelial nitric oxide synthase-derived nitric oxide in acute shock and Sudden Death Syn-
drome were described. The concepts, hypotheses, and conclusions in this paper provide
building blocks upon which future hypotheses can be generated and tested.
In a series of in vitro experiments, Pollack and coworkers have established that water
adjacent to hydrophilic surfaces (interfacial water) differs dynamically from bulk water
in several respects, including exhibiting up to ten times higher viscosity [55, 56]. Guo
and Friedman [57] and Tielrooij et al. [58] have provided data to support an earlier
prediction by Ling [59, 60] that even small organic molecules and solutes can induce
formation of “polarized oriented multilayers” of interfacial water.
Pollack and coworkers proposed the term “exclusion zone” for this interfacial water,
based on the observation that solutes and suspended particles were excluded from this
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proposes that the structured water along biological membranes forms hexamers [61]
that closely resemble the structure of ice. He wrote: “We found the honeycomb sheet
model more promising, its hexamers lying out of register with those of adjacent sheets.
This model could account for the EZ's net charge; plus, it has the advantage of prece-
dent because of its similarity to ice.” ([56], p. 68). Most likely, the exclusion zone is
built of such highly structured “liquid crystals” and it induces a charge separation with
a voltage drop across the interface with the surrounding bulk water, thus providing a
battery-like source of energy.
Del Giudice has compared this interfacial or exclusion zone (EZ) water with Prepara-
ta’s proposed water “coherence domains” (CDs), derived via a quantum electrodynamic
application of quantum field theory [62]. In earlier work, Preparata also likened water
to a plasma in the sense that it contains a roughly equal number of positively and nega-
tively charged particles and thus can conduct electricity and be influenced by magnetic
fields [63]. More recently, in a proposed continuum solvent model, Duignan et al. have
also described interfacial water as a coherent, plasma-like phase [64].
In addition to the evidence reported for special, “non-bulk” water zones near hydro-
philic surfaces [56], neutron reflectivity measurements of Doshi et al. have revealed
reversible changes in the size of a reduced-density water region near a model hydro-
phobic surface, depending on the amounts and kinds of dissolved gases present in the
water [65]. Their observation of a decrease in size of the lower-density region in the
water as gas concentration was reduced explains the hydrophobic effect and its report-
edly lower magnitude in degassed water [65]. Shatalov, Bunkin, and others have pub-
lished data pointing to an important role for ion-stabilized nanobubbles in modulating
interfacial water tension [53, 66, 67]. These studies of the effects of dissolved gases on
interfacial water properties provide important insights into the important role of
dissolved gases, such as NO, CO, and H2S, as vascular signaling molecules [68]. This
subject will be discussed further in Section (Electrokinetic vascular streaming potential)
below.
From this brief survey, we can see that essentially all types of surfaces and solutes
found in biological systems have important interactions with water that influence
interfacial water structure and tension. The sulfur-containing surfaces and solutes of
particular interest for maintaining healthy water properties in blood vessels include
the sGAGs that, as mentioned above, line the endothelial lumen, and Ch-S, which is
present in all cell membranes and, at low levels, in blood plasma [30]. David Grant’s
group has provided infrared and NMR spectroscopic evidence to support the view
that heparan sulfate proteoglycans (a type of sGAG) impart structure to water
in vivo [69]. Importantly, results of infrared photodissociation spectroscopy studies
have provided evidence of relatively long-range water ordering properties for sulfate
anions [70].
Moreover, one of the hydrophilic surfaces used prominently in Pollack’s studies of
EZs comprised sheets of the sulfonate-rich fluoropolymer NafionR [55, 56, 71]. Recent
studies of Pollack and coworkers with potential high relevance to water behavior in
blood vessels include observations on water flow through submerged NafionR tubes
[72] and elegant work on EZ formation near discontinuous NafionR surfaces [73].
Figure 1 depicts the capillary glycocalyx and shows how the NafionR-based tubes can
Fig. 1 a. Distribution of charge in the exclusion zone and water beyond the exclusion zone as shown by
electrical potential measurements and pH- sensitive dye studies. Protons spread in bulk water, although
some cling to the negatively charged EZ. b Disposition of charge anticipated in a tubular configuration.
(Reproduced from Rohani and Pollack, 2013 [72], with permission from the American Chemical Society.
Copyright © 2013)
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to Nafion strips, which draws parallels with the architecture of the glycocalyx.
The observations of Bunkin et al. of changes in electrostatic potential and the
refractive index of water provide additional evidence of a separate phase of water
near NafionR surfaces [74]. In addition, Zhao et al. have noted unexpected effects
of light on self-assembly of colloidal, sulfate-decorated particles near larger beads
in water [75].Fig. 2 NafionR strips spaced at 50, 100, 250 & 500 μm edge-to-edge. Exclusion zones form from the NafionR
surfaces and merge into an unbroken EZ in 50- and 100 μm-spaced lines. NafionR strips are seen as the
bright white squares on the images. At 250 and 500 μm the EZ forms in discrete zones that do not com-
bine. The yellow dashed lines demarcate edges of glass support. Dashed black lines indicate extent of clear
EZ. Diagram on the far right indicates the viewing height (arrow) on which the objective was focused.
(Reproduced from Figueroa and Pollack (2011) [73] with permission from WIT Press)
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In this section we consider the effects of interfacial water on blood flow in the vascular
system. The pumping action of the heart generates pressure that pushes blood through
blood vessels. This pressure-induced flow of the blood past the charged sGAGs lining
the endothelium generates an electric streaming potential. We will focus on consider-
ing a recent paper by Trivedi et al. [76], which demonstrated that the electrokinetic
vascular streaming potential (EVSP) caused by blood flow has significant biological ef-
fects on endothelial cells [76]. This paper may have solved in one stroke of genius the
mystery of why both elevated blood pressure and elevated heart rate might have benefi-
cial effects [76]. In fact, EVSP may be the most important contributor to vascular
health.
A key insight is that the blood is filled with negatively charged “particles” in colloidal
suspension, which includes both cells such as red blood cells (RBCs) and platelets, as
well as lipid particles such as LDL and HDL, serum proteins such as albumin and γ
globulins, and fragments of sulfurylated polysaccharides like heparan sulfate. A moving
charged particle creates an electromagnetic field, which can be used as a signaling de-
vice in biological systems. What Trivedi et al. [76] have shown is that endothelial cells
respond to these electromagnetic signals by producing nitric oxide, which has been
identified as the endothelial-derived relaxing factor (EDRF) in arteries and veins [77].
The signal has both a DC and an AC component. The AC component is synchronous
with the heart rate, as the suspended particles accelerate and decelerate in response to
the force field of the beating heart. The paper showed that there was a significant
(nonlinear) increased response to a 2Hz signal (corresponding to a heart rate of 120
beats per minute) compared to a 1Hz signal (60 bpm). Hence, increasing heart rate has a
direct effect of inducing increased NO production, and therefore vascular relaxation [77].
Figure 3 provides a schematic of the principle that vascular flow is critically
dependent on the negative charge provided by sulfate ions attached to the glycosamino-
glycans in the capillary wall and to cholesterol in the plasma membrane of red blood
cells. Electrostatic repulsion prevents RBCs from adhering to the capillary wall, and theFig. 3 Schematic of the bottle brush structure of the glycocalyx, including the lipid bilayer at the top, and
the branching trees of glycosylated proteins with sulfates in the heparan sulfate chains providing negative
charge and kosmotropic effects on the surrounding water, with strong analogies to Pollack’s NafionR strips
experiments shown in Fig. 2
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kosmotropic properties of sulfate, provides a smooth surface further protecting from
adhesion. The RBCs are propelled toward the venous end of the capillary by the elec-
tromagnetic field induced by the voltage drop across the capillary. The RBCs them-
selves act as moving charged particles that create a circular magnetic force around the
capillary wall. This force induces nitric oxide release from the endothelial cells, which
promotes vascular relaxation and increases flow.
The experimental results presented in [76] virtually prove, by process of elimination,
that structured water in the interphase of the endogenous biofilm of the endothelial
glycocalyx is the “target” of the EVSP. Based in substantial part on Trivedi et al. [76],
we propose the hypothesis that interfacial water is also the target of extremely low fre-
quency electromagnetic (ELF EM) energy from the environment, in vivo, including that
energy afforded by the EVSP to the interfacial water found in the EGL of the vascular
endothelium, systemically, including that of the heart.
We find to be quite striking the interpretations derived from the seminal experiments
in the Trivedi [76] paper, which demonstrated that the effect of EVSP on the NO signal
is not simply tied to the depolarization effect on the endothelial cells. They propose
several sites of action of the ELF fields on the pathways that are directly responsible for
producing the NO signal in the presence of extracellular calcium. Their experiments
with ELF electrical stimulation under calcium-free solutions show increases in NO pro-
duction in an amplitude- and frequency-dependent manner. The conclusion is that the
field itself acts on a target that potentiates NO production without requiring calcium
flux.
Having excluded many of “the usual suspects” as targets of the ELF EM field of the
EVSP, including those associated with calcium flux, Trivedi et al. suggest that “the likely
mechanism that links these fields to cellular effects is the electroconformational coup-
ling of an applied periodic electric field to membrane-associated processes, which has
been established both theoretically and experimentally.” [76] Of course, this view is
fully compatible with the EIWS theory, in which an underlying tenet is that protein
structure and function are “slaved” to biological water dynamics [78], and effectively
invites our proposal that a logical candidate for the biological target of the ELF EM
energy of the EVSP is the interfacial water itself.
The classical formula for streaming potential, known as the Helmholtz-Smoluchowski
(HS) equation, is very enlightening, because its magnitude is proportional to zeta potential
and blood pressure, and inversely proportional to blood viscosity. Zeta potential, in turn,
depends on the amount of negative charge around the charged particles. According to
A.V. Delgado et al. [79], electrokinetic or zeta-potential, ζ, is identified as the potential at
the plane where slip with respect to bulk solution is postulated to occur ([79], p. 1759).
When RBCs are deficient in Ch-S in their membranes, this will be reflected in a lowered
(less negative) zeta potential. This can be counterbalanced by increasing the blood pres-
sure to compensate, which could be the main beneficial effect of high blood pressure, a
so-called “pathological” condition associated with cardiovascular disease.
Furthermore, viscosity, the denominator term in the HS equation, can also be manipu-
lated by reducing the total count of RBCs in circulation. This will have a significant effect
in reducing viscosity, thus increasing EVSP. This may be the source of the essential
anemia associated with certain end-stage diseases like kidney failure and cancer [80, 81].
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to do with insufficient sulfate synthesis by eNOS. When zeta potential falls (to less nega-
tive values) due to insufficient supplies of sulfates to maintain adequate negative charge
around RBCs and other suspended particles, a compensatory mechanism sets in, for ex-
ample through increased hepcidin synthesis and reduced erythropoietin-induced renewal
of RBCs [83]. RBCs also experience a shorter lifespan when they are deficient in Ch-S
[84], promoting a reduction in the hematocrit and therefore in blood viscosity.
It should be noted that the HS equation assumes homogeneity of the inner tube sur-
face through which the fluid flows, but this situation might not apply at the capillary
scale, where the electrical double layer (EDL) of vicinal water is strongly curved, polar-
ized, anisotropic and surface conductive, and the interface is heterogeneous [85]. In
addition, Bharti et al. [86] found that electroviscous effects on flow through cylindrical
microchannels were stronger in shear-thinning liquids (for which viscosity decreases
with increasing shear stress) than in Newtonian liquids (which display a linear response
between applied shear stress and deformation rate). Human blood plasma is thought to
behave as a shear-thinning liquid, just as do many biological solutions of protein and
DNA [87].
Moreover, theoretical studies by Zhao et al. [78] indicate that the HS velocity of non-
Newtonian fluids through cylindrical microchannels depends on the channel radius, an
effect they attributed to nonlinear coupling among the electrostatics, channel geometry,
and non-Newtonian hydrodynamics [78]. They also proposed a method for enhancement
of electro-osmotic flows of power-law fluids under a combined DC and AC electric field
[78], such as would be introduced by the beating heart.
Our final comment on the finding of EVSP-induced release of NO by endothelial
cells relates to the biophysics of dissolved gases such as NO, CO, and H2S, which play
complex signaling roles in blood homeostasis [68]. As noted in Section (The Exogenous
Interfacial Water Stress (EIWS) theory of inflammation) above, Doshi and coworkers
found that the size of a reduced-density water region near a hydrophobic surface
depended strongly on the amounts and types of dissolved gases present [65], which
could in turn influence the interaction between hydrophobic surfaces and the water in
between them. They proposed further that lower-density water near a surface “should
reduce their viscosity and boundary conditions for flow… from no-slip to partial or
full-slip, which will have a significant impact on transport properties in small channels
and on drag reduction in general” [65]. Their work maps directly to properties of the
endothelial surface in capillaries, likely reflected as near frictionless flow or squeezing
of RBCs through capillaries whose internal diameters of ca. 4–9 μm are nearly the same
or even smaller than the average RBC diameter of ca. 7.8 μm [88].
Biosulfates as enablers of healthy blood flow
With the remarks made in the previous two sections, we can begin to see how bio-
logical sulfates in the vascular system can influence important properties relating to
interfacial water structure and blood flow. In this section we will continue our discus-
sion with a more detailed consideration of how biosulfates, most notably sGAGs and
Ch-S, may play essential roles in maintaining blood flow and electrokinietic properties.
As discussed earlier [49], sulfurylated glycolipids, sGAGs, and sterol sulfates, including
Ch-S, are ubiquitous in biological systems. These biosulfates generate the net surface
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bio-membrane viscosity and permeability [49]. They are also expected to have strongly
electron-donating inductive effects on interfacial water.
To start our more detailed discussion, we propose that the HSPGs decorating the
endothelial glycocalyx layer (EGL) of capillary endothelial cells provide a bottle-brush
architecture similar to that reported by Banquy et al. for a synthetic mimic of the lubricat-
ing protein lubricin [89]. Figure 4 provides a schematic of the bottle-brush architecture of
the glycocalyx. We suggest that the roughness of the bottle-brush, HSPG-decorated EGL
induces capillary behavior of the blood, as implied by the molecular theory of capillarity
[90]. This capillarity, when aided by (a) the amphiphilic Ch-S in endothelial and erythro-
cyte membranes and blood plasma, (b) a high (negative) ZP, and (c) high interfacial water
tension, effectively facilitates the electrokinetic pulling of deformable RBCs through the
microvasculature.
Sherman [91] has argued, through simple physical considerations based on Laplace’s
equation of capillarity, that blood will flow out of capillaries into both the arteries and
the veins when the surface tension is too high in the capillary, due to the inverse rela-
tionship between the size of the vessel and the pressure [91]. (We use the term “surface
tension” here to refer to the amount of work needed to create an extra unit of liquid
area at a liquid–vapor interface, while “interfacial tension” is understood to apply to the
amount of work needed to create an extra unit of liquid area at a liquid-liquid or
liquid–solid interface.) Interfacial water tension within a capillary lumen has both an
endothelial water interface component and an erythrocyte water interface component,
which may be represented by vectors normal to the endothelial and erythrocytic
surfaces, respectively. We propose that, to avoid an intracapillary no flow or no reflow
phenomenon, these vectors must dynamically negate each other’s force. We argue that
anionic amphiphilic surfactants are essential to maintaining this balance. Cationic
kosmotropes (water-structuring solutes) typically contract the surface (increase the
surface tension), whereas anionic kosmotropes typically expand the surface (decrease
the surface tension). The rate of surface tension lowering of anionic surface-activeFig. 4 Schematic of a red blood cell moving through a capillary, propelled by the force field generated by
the voltage drop between the artery and the vein. The moving RBC creates an electromagnetic field that
induces the release of nitric oxide from the capillary wall. This relaxes the vessel and further promotes flow
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When an ionic surfactant is used to produce bubbles [93], the sign of microbubble
charge is determined by the polar head of the surfactant.
More specifically, we propose that Ch-S acts as the key biosurfactant enabling healthy
blood flow in the microvasculature, fulfilling a role similar to that played by sodium
dodecyl sulfate (SDS) in SDS- polyacrylamide gel microelectrophoresis. In recent high-
speed video studies of aqueous droplets moving electrophoretically through oil, Hamlin
et al. found that, at relatively low or high surfactant concentration, the droplets
responded to reversal of the electric field by quickly accelerating and then decelerating
in the opposite direction, “concurrent with a transient rearrangement of tracer particles
on the droplet’s surface” [94]. Of note, one of the surfactants, SDS, is structurally simi-
lar to the amphiphilic sterol sulfate, Ch-S. Hence, the role we have postulated for Ch-S
in enhancing microvascular blood flow might involve facilitation of a metastable
Marangoni-type fluctuation in mass transfer along the interface due to changing sur-
face tension gradients. This effect would enable erythrocytes to flow, in conjunction
with ELF EM energy provided under our hypothesis, to the EGL target by the EVSP.
The thorough studies of Colacicco dealing with the role of SDS in the electrical poten-
tial at an oil–water interface [95] also have implications with respect to how Ch-S
might be involved in generation and maintenance of the cellular resting electrical po-
tential, action potential, electrokinetics, and zeta potentials.
Before closing this section, it is worth noting that Davidson and Seneff [49, 50] have
proposed yet another way in which sulfur insufficiency may give rise to impaired blood
flow. While the cardiovascular complications of diabetes are often attributed to loss of
nitric-oxide-mediated vasodilation, an alternative pathophysiology was suggested,
involving impaired microvascular perfusion due to (a) decreased fluidity and deform-
ability of the RBC membrane related to biosulfate deficiency in the endothelial glycoca-
lyx layer (EGL); and (b) increased capillary endothelial interfacial (surface) tension [49,
91]. This proposed mechanism disagrees with Burton’s basic assumption of flow being
arrested by active arteriolar constriction [91–96].
If adequate supplies of sulfate are essential for maintaining blood vessel health,
then the organism needs the capability to redistribute existing sulfate resources
wherever needed in the cardiovascular system and to convert (oxidize) more-
reduced sulfur compounds to sulfate if other sources of sulfate are insufficient. As
mentioned above, we previously proposed an eNOS- and sunlight-catalyzed mechan-
ism as a normal route for sulfate biosynthesis [16]. In the following three sections of
the present paper, we will consider sulfate redistribution mechanisms and alterna-
tive, emergency sulfate synthesis pathways that generate, as side effects, various
forms of blood vessel damage and other symptoms associated with cardiovascular
disease.Extracellular matrix sGAG turnover as a mechanism for sulfate redistribution
In the preceding section, we presented our hypothesis that Ch-S plays an essential role
in enabling healthy blood flow through the capillaries. In this section, we discuss the
deposition of cholesterol in the cardiovascular system when insufficient sulfate is
available to make Ch-S. We will then propose a mechanism by which capillary levels of
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sGAG turnover in the extracellular matrix (ECM) of atherosclerotic regions.
Cholesterol is made by all cells in the body, but, being lipophilic, does not easily
migrate from intracellular synthesis or storage sites to the plasma membrane. Sulfuryla-
tion will make the molecule amphiphilic, enabling it to facilitate blood flow through
capillaries as discussed above, and reducing or eliminating the need to package choles-
terol inside a lipoprotein particle for transport within the water-based cell cytoplasm.
In addition, Ch-S shows a 10-fold higher rate of exchange between two lipid mem-
branes than does cholesterol [97], which can be expected to greatly accelerate uptake
by HDL, the lipoprotein that can remove cholesterol from the atheroma.
ApoE is the lipoprotein that escorts Ch-S from the Golgi apparatus to the plasma
membrane, and ultimately delivers it to HDL-A1 [98]. ApoE’s antioxidant properties
probably allow it to protect Ch-S in transit from oxidative damage. Indeed, ApoE pro-
motes both cholesterol egress from the macrophages in the plaque and sulfurylation of
the glycocalyx [98], and this hints that Ch-S might play an intermediary role.
SULT2B1b is the specific sulfotransferase that sulfurylates cholesterol. It also sulfury-
lates oxysterols such as 7α-hydroxycholesterol and 27-hydroxycholesterol with nearly
the same affinity [99]. Sulfurylation significantly reduces the cytotoxicity of these oxy-
sterols, which are present in the atheroma. It is plausible that oxysterols, which are
more water soluble than cholesterol itself, are exploited to deliver sulfate to the extra-
cellular matrix.
Platelets also tend to accumulate in cardiovascular plaque, and, if supplied with acti-
vated sulfate in the form of PAPS, they exuberantly produce Ch-S [100]. They release
it, specifically, to HDL-A1 [98]. They will accept no other lipid particle as the recipient.
Significantly, HDL-A1 is the only form of HDL that is atheroprotective [101].
There is strong evidence from studies on plaque formation that cholesterol is actively
recruited into the atheroma. Contrary to the widely perceived model that cholesterol
passively enters the artery wall from the luminal side, a provocative paper published by
Subbotin in 2012 [102] proposed that cardiovascular disease is initiated by neovascular-
ization of the tunica intima, and that cholesterol is actively recruited directly from the
newly formed capillaries. He also argues that this process begins early in life. We
propose that this cholesterol is accumulated as a reserve supply, which will be conju-
gated with sulfate to form Ch-S as soon as sulfate becomes available.
A study on the export of cholesterol from macrophages in cardiovascular plaque into
plasma discovered that only 40 % of the cholesterol was extracted into HDL-A1, and a
significant percentage of the rest, surprisingly, was extracted by serum albumin [103],
despite the fact that the cholesterol acceptor activity for albumin is 280-fold lower than
that of apoA1. This supports our hypothesis that it is sulfoconjugated prior to export.
Ch-S and DHEA sulfate bind tightly to albumin, in direct contrast to their unsulfury-
lated counterparts [30, 104]. Furthermore, increased uptake by albumin was associated
with increased risk to cardiovascular events [103]. We hypothesize that this may reflect
Ch-S depletion in albumin. DHEA sulfate, but not DHEA, inhibits NF-κB synthesis,
suggesting that sulfate deficiency is a driver of inflammation [105].
Clearly, insufficient sulfate supplies will impair production and transport of Ch-S to
the microvasculature to fulfill its proposed surfactant and electrophoretic functions as
described in Section (Biosulfates as enablers of healthy blood flow) above. In the
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fate needed for Ch-S can be harvested by taking advantage of sGAG turnover in the
extracellular matrix (ECM) of the cardiovascular system.
The sGAG-rich glycocalyx plays an important regulatory role in vascular permeability
[106]. The sulfurylation patterns in these complex sugar chains are intricate and tightly
regulated [107]. Changes in vascular glycocalyx structure regulate cellular adhesion,
proliferation, migration and signalling in association with cardiovascular disease [108].
Extracellular proteoglycans, including sGAGs and the sulfate-free hyaluronan (HA),
maintain hydration, mechanical properties, and concentration gradients of critical sig-
nalling molecules [109].
A remarkable series of investigations by Hauss et al. in the 1960’s [110, 111] mea-
sured the uptake of sulfur into sGAGs in the artery wall and its biological half-life as
a function of age. Their studies revealed that the amount of sulfur that is taken up by
the sGAGs is highest very early in life and decays exponentially over time, and that
the retention cycle also decreases with age. However, the incorporation of sulfur into
sGAGs in diseased regions where cardiovascular plaque accumulates is several fold
higher than what would be predicted based on the age curve (see Fig. 5). The sim-
plest explanation is that the atheroma is actively engaged in accumulating sGAGs for
redistribution.
Hyaluronan (HA) concentration is increased dramatically in association with smooth
muscle cell migration and proliferation following arterial injury, along with that of
versican, a chondroitin-sulfate-enriched proteoglycan [112]. Both HA and versican are
found in high concentrations in atherosclerotic plaque, particularly in association with
the trailing edge of migrating smooth muscle cells. A postmortem study of stented
arterial regions showed that chondroitin sulfate and HA were the predominant compo-
nents of the neointimal proteoglycans [113], and vessel injury at the stent site was
proposed as a factor inducing this buildup. Like the sulfate and sulfamidate groups of
sGAGs, the multiple carboxylate groups attached to HA could also effect a structuring
of the surrounding water [50], resulting in a clear solute free zone surrounding theFig. 5 Sulfur Incorporation into GAGs with Age. Incorporation of 35Sulfur into chondroitin sulphuric acids
(CSA) of the connective tissue of normal human aortae (x) and atherosclerotic human aortae (o) in in vitro
experiment. (Redrawn from [110], with permission from Elsevier)
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graded, the versican is also released into the surrounding space.
A pericellular matrix gel forms around these aggregated HA-versican fibrillar com-
plexes produced by migrating smooth muscle cells but then appears to dissolve into
the medium about one hour later [112]. The main purpose of the matrix may well be
to produce materials (HA and versican) that can be degraded to enable redistribution
of the building blocks to distant cells. This degradation can be accomplished with NO
and/or one of its reactive oxidant derivatives. NO gas degrades heparin and heparan
sulfate (HS) at concentrations as low as 400 ppm. NO oxidizes rapidly to HNO2, which
can also break down HS chains that are attached to membrane proteins such as syndi-
cans and glypicans [114]. On the other hand, peroxynitrite (ONOO−), the product of
reaction of NO with superoxide, is particularly effective at breaking down HA, which
will permit the release and redistribution of fragments of both HA and the attached
chondroitin sulfate chains, thereby providing a sulfate source to replenish depleted sup-
plies in the myocardial microvasculature.
In support of this hypothesis, Kruse et al. have reported that significant decreases in
HS content and increases in the amounts of chondroitin sulfate/dermatan sulfate rela-
tive to HS are observed in association with elevated cholesterol levels in human aorta
[115]. Thus, there is an inverse relationship between cholesterol retention and heparan
sulfate supply. Furthermore, the observed redistribution of sGAG content away from
HS (which inhibits smooth muscle cell proliferation) toward chondroitin sulfate-rich
GAG is consistent with a move toward enabling smooth muscle proliferation to free up
stored sulfate for possible use in generating Ch-S.
An in-depth discussion of the connection between diabetes and CVD is beyond the
scope of this paper, but it is worth noting that the advanced glycation end products
(AGEs) associated with hyperglycemia and diabetes also trigger processes that promote
inflammation and smooth muscle cell proliferation, leading to generation of reactive
oxygen species (ROS) and induction of an atherosclerotic profile [116]. Oxidative stress
is a well-established risk factor for vascular disease [117]. H2S, in addition to its
antioxidant effects, can protect from diabetes by increasing the cellular levels of
phosphatidylinositol 3,4,5-trisphosphate (PIP3), a positive regulator of glucose metabol-
ism [118].
Glutathione and GGT
In the preceding section, we discussed a possible mechanism by which the cardiovascu-
lar system could relieve a shortage of Ch-S and avoid a crisis in capillary blood flow by
redistributing sulfate from sGAGs. We will now turn our attention to ways in which
the total biosulfate supply can be replenished by “emergency” conversion of less-
oxidized sulfur compounds. As noted in Section (Evidence for a role of sulfur defi-
ciency in atherosclerosis) above, we have proposed elsewhere [16] that, under normal,
non-inflammatory conditions, sulfate synthesis from thiol- and sulfane-type substrates
(HS−, glutathione persulfate, thiosulfate, etc.) in RBCs, platelets, and other endothelial
cells can be facilitated by eNOS and sunlight. In the present section, we will consider
other sulfate biosynthesis routes from thiols that can be utilized if sunlight exposure is
inadequate or if eNOS function is impaired through exposure to environmental
toxicants.
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systems more generally [119]. Plants utilize glutathione (GSH) as the main form of
reduced sulfur storage [120]. The concentration of GSH is much higher than the con-
centration of free cysteine in plant cells, and this may be because it is less reactive than
free cysteine, and therefore more attractive for sulfur storage. The same may be true
for animals. A study exposing rats to a GSH synthase inhibitor resulted in a three-fold
reduction in tissue GSH along with indicators of oxidative stress and hypertension.
This was linked to reduced synthesis of nitric oxide (NO) in the vascular wall [121].
This relates to the observation, now thoroughly confirmed, that elevated γ-glutamyl
transferase (GGT), an enzyme that breaks GSH down into its component amino acids,
is an outstanding serum marker for a host of modern diseases, including liver dysfunction,
cardiovascular disease [122, 123], digestive disorders, Alzheimer’s disease, metabolic
syndrome, obesity, diabetes, musculoskeletal disorders, cancer and death [124–127], with
high significance. Ischemia depletes glutathione in both liver [128] and brain [129].
Elevated serum GGT strongly predicts carotid plaque, which, in turn, is highly predictive
of future cardiovascular disease [130].
While GSH is mostly known as an antioxidant, extracellular GSH can exhibit a pro-
oxidant effect in the presence of GGT [131]. GGT, by splitting off glutamate, produces
cysteinyl glycine, which is more acidic than glutathione (pKa 6.4 vs. 8.56, respectively)
[132], making it more reactive in converting Fe+3 to Fe+2. However, another factor that
may be at play is the fact that the carboxylate group of the glutamate residue in GSH
chelates with iron, reducing its bioavailability for reaction with the sulfhydryl group of
the cysteine moiety [133]. GGT separates the glutamate from the other two amino
acids, facilitating iron reduction to Fe+2 and subsequent redox reactions. In the pres-
ence of free iron (Fe+3), this can lead to the Fenton reaction and subsequent production
of superoxide.
While the research literature does not provide any explanation for a possible benefi-
cial effect of this superoxide production, we propose that it is necessary in order to pro-
mote oxidation of the sulfur atom in cysteinyl-glycine to sulfate. We hypothesize that
cysteine is liberated from GSH for subsequent breakdown to supply sulfur as a
substrate for sulfate production. In oxidative cysteine catabolism, cysteine dioxygenase
oxidizes the sulfur in cysteine, leading ultimately to the production of taurine, pyruvate
and sulfate [134]. Cysteine might also be converted to homocysteine and subsequently
homoycysteine thiolactone, which can also be substrate for sulfate synthesis through a
pathway requiring vitamin C and vitamin A as well as superoxide [17]. Elevated serum
homocysteine is a strong risk factor for cardiovascular disease [14, 135–137]. In fact,
homocysteine is known to induce vascular oxidation damage [138, 139]. We propose
that the need for homocysteine and for superoxide is driven by the insufficient supply
of Ch-S to the tissues.
Another available pathway is to produce hydrogen sulfide gas (H2S) from cysteine by
enzymatic action of cystathionine γ lyase (CSE). H2S has only relatively recently been
recognized as a signaling gas on par with nitric oxide [68], and it has been shown to
induce vascular relaxation as well [140]. H2S offers similar protective effects as NO
without the issue of reacting with superoxide to produce the toxic metabolite ONOO−
[141–143]. H2S in small concentrations promotes angiogenesis and protects against
both atherosclerosis and hypertension [144]. CSE is present in both vascular smooth
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ized that H2S can be used by mammalian mitochondria as an energy source during
times of hypoxia.
In experiments on vascular smooth muscle cells, it was shown that stress-induced
calcium entry causes CSE to migrate to the mitochondria, where cysteine is already
available in high concentration [146]. These authors wrote: “The notion that eukaryotes
do not need H2S in the energy metabolism process should be revised. In SMCs, mito-
chondrial CSE translocation and H2S production confer resistance to hypoxia by in-
creasing ATP synthesis.” We argue that, in addition to this, it is also an important
substrate for sulfate synthesis. The CSE enzymatically produces H2S from cysteine,
along with pyruvate as a by-product, another energy source that also reduces electron
leakage. H2S is quickly oxidized by the electron transport chain to sulfate and thiosul-
fate [146], and helps maintain ATP levels in a hypoxic environment. Thiosulfate can be
converted to sulfate in a reaction catalyzed by thioredoxin reductase, which can be used
in certain microorganisms and possibly even in mammalian cells as an energy source
for further ATP production, restoring H2S and completing the cycle [147].
We can now explain the refractory statin resistance observed in the context of certain
highly inflammatory conditions such as lupus or kidney failure. Here, cardiovascular
mortality is increased by up to 33 to 50 fold [148], yet, despite this, serum LDL is often
not elevated, or may even be abnormally low. A recent investigation revealed that, in
these cases, smooth muscle cells in the aorta use coenzyme A reductase to synthesize
their own cholesterol for local storage, and these cells show resistance to statin therapy
compared to hepatic cells [3]. This suggests to us that the cholesterol is desperately
needed to maintain blood stability.
Although supportive evidence of our hypothesis is strong, further in vitro studies
specifically addressing the concept of cholesterol sulfate’s role in protection from
atherosclerosis are needed. In addition, clinical trials involving dietary modification to
include enrichment in sulfur-containing amino acids and other sulfur sources, along
with increased sun exposure to the skin and avoidance of environmental toxicants, will
be an important step towards validating our hypothesis.
Conclusion
In this paper, we have put forward the novel hypothesis that impaired cholesterol sul-
fate supply to the heart is the key pathology behind atherosclerosis. This explains why
regions of the artery wall with increased sulfate uptake and recycling in the endothelial
glycocalyx also have excess cholesterol storage. We offer key insight into the import-
ance of sulfates to vascular health through arguments based on the unique properties
of water and the EIWS theory of disease. We hypothesize that CYP enzyme disruption
by multiple environmental toxicants may be a significant factor in atherosclerosis, as
eNOS contains a CYP structural motif that is likely essential for sulfate synthesis. We
argue that the accumulation of cholesterol in the artery wall is a reflection of impaired
cholesterol transport due to low bioavailability of sulfate to the vasculature. The con-
stant remodeling of the extracellular matrix in occluded arterial regions reflects the
need to break down and distribute to the capillaries the sGAGs that must populate the
glycocalyx to maintain vascular health and enable blood flow. Supportive evidence
comes from the observation that the differentiation, mobilization, and proliferation of
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sulfate.
While the view that atherosclerosis is an inflammatory disease is gaining in popularity
today [149], anti-inflammatory pharmaceutical drugs increase the risk to heart disease
[150]. Elevated homocysteine is a strong risk factor for atherosclerosis, yet attempts to
correct it have met with failure. Administration of B vitamin supplements in an attempt
to reduce serum homocysteine has been effective, but did not result in any clinical im-
provement in cardiac disease risk [151–153]. All of these seemingly contradictory results
can be explained if we assume the point of view that the inflammation is needed to induce
superoxide production, which will allow sulfate production with homocysteine, H2S, and
superoxide as substrates. Any attempt to reduce either the superoxide or the homocyst-
eine levels will further impair the supply of sulfate to the capillary glycocalyx.
Platelet complement activation, a key factor in atherogenesis, leads to inflammation
and thrombosis, both of which may be necessary for the intense regeneration of sulfate
at the injury site and its mobilization, in order to restore vascular health. A recent re-
view article on platelet activation summarized as follows: “We hypothesize that platelets
focus complement activation to sites of vascular injury, and that interactions between
platelets and the complement system contribute to acute and chronic inflammation
and thrombosis.” ([154], p. 5). We have argued here that the inflammation renews sul-
fate supplies and the thrombosis reduces viscosity. Vascular flow is improved, and this
leads to nitric oxide production, mediated by EVSP. Nitric oxide reaction products
break down and redistribute locally-produced sGAGs.
Based on a review of the literature, this paper describes several novel means by which
the biosulfates play essential roles in enabling microvascular blood flow, including their
impact on the hemorheological parameters - the zeta potential, streaming potential, ca-
pillarity, viscosity, and interfacial tension, without which a “no flow” situation would
surely exist. It argues that lifestyle is causal and simple lifestyle changes may have
profound benefits. These include eating strictly organic sulfur-rich foods and making
special efforts to avoid environmental toxicants and to promote sun exposure to the
skin without sunscreen.
Endnotes
1Throughout this paper, as a significant nomenclatural point, we have adopted use of
the words “sulfurylate” and “sulfurylation,” in strong preference to the words “sulfate”,
“sulfation”, and “sulfonation”. Biochemically, sulfate ester and sulfamidate formation
occur most commonly via sulfuryl group transfer. Use of the term “sulfation” is likely
to only apply to in vitro electrophilic aromatic substitution and olefinic addition reac-
tions, which involve carbocation intermediates. Whereas in vivo only 3 oxygen atoms
transfer with the sulfuryl group to an acceptor ROH or RNH2 molecule to produce a
sulfate ester or sulfamidate, respectively. Such a mechanism of “sulfuryl” group transfer
via “sulfurylation” has important mechanistic implications, which are highly-analogous
to “phosphoryl” group transfer via “phosphorylation” in organophosphorus chemistry.
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